Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$24.38
+1.79%
Mkt Cap $2.26B
Analyst Ratings
No recent rating data.
Price Target (42 analysts)
$51.50
Range $34.00 – $67.00
Implied Upside
+111.2%
Consensus $51.50 vs current $24.38